Stay updated on Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T19:07:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T14:51:15.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-02T13:29:33.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The webpage has updated its results reporting dates and added detailed criteria for evaluating adverse events related to study treatment, while removing previous references to serious adverse events and specific submission dates.
    Difference
    8%
    Check dated 2025-07-26T12:05:37.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a planned maintenance alert starting July 25th, during which most services will be unavailable for over 24 hours. Additionally, the version has been updated from v2.16.5 to v2.16.6.
    Difference
    0.9%
    Check dated 2025-07-19T10:43:16.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.16.5) and indicates that results have been submitted, while previous information about the modernization of ClinicalTrials.gov data ingest and the absence of posted results has been removed.
    Difference
    1%
    Check dated 2025-07-05T02:28:46.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Head & Neck Squamous Cell Cancer Clinical Trial page.